🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 7 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/08/1997 43,88 44,25 42,38 44,25 +4,42% 4,27% 9.350
13/08/1997 45,00 45,00 42,38 42,38 -5,04% 5,83% 3.900
12/08/1997 42,75 45,00 42,75 44,63 +6,25% 5,26% 14.400
11/08/1997 41,63 42,75 40,88 42,00 +1,82% 4,50% 10.200
08/08/1997 40,88 41,63 40,88 41,25 +0,00% 1,83% 1.383
07/08/1997 39,75 41,25 39,00 41,25 +3,77% 5,66% 16.750
06/08/1997 39,38 40,13 38,63 39,75 +2,91% 3,81% 3.300
05/08/1997 39,00 39,38 38,63 38,63 -0,96% 1,92% 1.333
04/08/1997 40,13 40,50 39,00 39,00 -2,80% 3,74% 1.483
01/08/1997 40,50 40,50 39,75 40,13 +0,00% 1,85% 2.100
31/07/1997 39,38 40,50 39,38 40,13 +1,90% 2,86% 10.050
30/07/1997 40,13 40,50 39,00 39,38 -1,87% 3,74% 5.133
29/07/1997 40,13 40,13 39,00 40,13 +1,90% 2,80% 4.183
28/07/1997 39,00 39,75 39,00 39,38 +0,96% 1,92% 4.850
25/07/1997 40,50 40,50 39,00 39,00 -1,89% 3,70% 3.167
24/07/1997 39,00 40,50 39,00 39,75 +2,91% 3,85% 8.967
23/07/1997 41,25 41,25 38,25 38,63 -3,74% 7,27% 4.333
22/07/1997 40,50 41,63 40,13 40,13 -0,93% 3,70% 4.083
21/07/1997 42,00 43,13 40,50 40,50 -3,57% 6,25% 5.733
18/07/1997 43,50 43,50 42,00 42,00 +0,00% 3,45% 3.900
17/07/1997 41,63 43,50 40,88 42,00 +3,23% 6,31% 5.400
16/07/1997 39,75 40,88 39,00 40,69 +4,33% 4,72% 3.883
15/07/1997 39,00 39,38 38,25 39,00 +0,00% 2,88% 2.850
14/07/1997 40,50 40,50 39,00 39,00 +0,00% 3,70% 5.033
11/07/1997 40,13 40,13 39,00 39,00 -2,80% 2,80% 650
10/07/1997 40,13 40,13 40,13 40,13 +2,88% 0,00% 283
09/07/1997 42,75 42,75 39,00 39,00 -7,14% 8,77% 5.500
08/07/1997 43,50 43,50 42,00 42,00 -3,45% 3,45% 9.600
07/07/1997 44,25 44,25 42,38 43,50 +0,87% 4,24% 6.517
03/07/1997 44,25 45,00 43,13 43,13 -0,86% 4,24% 8.450